[ACL] YoY Quarter Result on 31-Dec-2023 [#Q2]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
29-Dec-2023
Financial Year
2024
Quarter
31-Dec-2023 [#Q2]
Profit Trend
QoQ- 100.00%
YoY- -80.52%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 333,719 360,312 538,001 317,904 245,491 7.97%
PBT 7,806 32,756 184,944 81,274 -4,217 -
Tax 2,731 7,274 54,656 24,201 -1,017 -
NP 4,952 25,421 130,214 57,073 -3,200 -
Tax Rate -34.99% -22.21% -29.55% -29.78% - -
Total Cost 328,767 334,891 407,787 260,831 248,691 7.22%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin 1.48 7.06 24.20 17.95 -1.30 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS 0.02 0.13 0.65 0.28 -0.02 -
EPS Diluted 0.02 0.13 0.65 0.28 -0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.